Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.
about
Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genesOver-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesityInhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in miceObesity: Current and potential pharmacotherapeutics and targets.Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice.Neuroimaging, gut peptides and obesity: novel studies of the neurobiology of appetite.Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis.CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese miceDifferential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype.The endocannabinoid system links gut microbiota to adipogenesisA novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodentsCentral and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditureKrill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjectsCannabinoids inhibit insulin receptor signaling in pancreatic β-cells.Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue.Endocannabinoid signal in the gut controls dietary fat intake.Endocannabinoids: an appetite for fatIntestinal lipid-derived signals that sense dietary fat.The role of gastrointestinal vagal afferent fibres in obesity.Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons.Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels.Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-TetrahydrocannabinolEndocannabinoids--at the crossroads between the gut microbiota and host metabolism.Gut microbiota, obesity and diabetes.Modulation of mouse gastrointestinal motility by allyl isothiocyanate, a constituent of cruciferous vegetables (Brassicaceae): evidence for TRPA1-independent effects.Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats.Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker ratsAnticipatory and consummatory effects of (hedonic) chocolate intake are associated with increased circulating levels of the orexigenic peptide ghrelin and endocannabinoids in obese adultsFasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathwaysCannabinoids induce pancreatic β-cell death by directly inhibiting insulin receptor activation.Sex-related differences in small intestinal transit and serotonin dynamics in high-fat-diet-induced obesity in mice.The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma.Blockade of cannabinoid 1 receptor improves GLP-1R mediated insulin secretion in mice.Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility.Impulsive-choice patterns for food in genetically lean and obese Zucker ratsEndocannabinoid signaling in the gut mediates preference for dietary unsaturated fatsFatty Acid modulation of the endocannabinoid system and the effect on food intake and metabolism.Liver fatty acid-binding protein binds monoacylglycerol in vitro and in mouse liver cytosol.Endocannabinoids in the Gut
P2860
Q21090979-2D362727-FB4D-4E5D-AD13-3FCD7B11540EQ27321622-27B84CDF-4C43-4697-81DE-54B4CFAD3165Q28258759-1ADD5FA5-04BB-4F7C-8D21-D691558FEC80Q30243992-4EBA3B21-FB5E-4A3A-A1B8-7308E29C72CFQ33451202-51027D35-F501-4364-AE6B-0B4722E986C7Q33606106-D110DC0F-C5C2-452C-8FE7-1918174F47CEQ33631151-136A2FFF-CFAA-4FAB-89BC-898D8DBFF782Q33750744-76A3C659-B634-4196-9F19-4901AE432A7AQ33846570-68594876-308F-4B66-B721-FAC1B6249B86Q33994763-0E6A6ACD-F26B-48E0-A050-F74E35695B26Q34078880-1AF7F6B6-3953-40D4-8707-C67F61854F87Q34140803-ACF10CB4-54EC-4315-97E4-F3CFE52D2725Q34617168-8C8DC817-4682-4715-9C26-102E6C63F5CBQ34623269-CA105FB3-45CC-4389-9E61-A260CA969DF8Q34718769-03517D4D-BAC0-401A-8AE9-3BCD09306055Q35114027-194184D0-BC28-47A5-84A9-B169336F8935Q35149416-07D847E1-B0AB-41F8-8425-491DDEBDB402Q35149641-D7B8B661-582C-4734-B49F-51C4F60F0B66Q35183977-121FD8AB-BA53-420A-B338-3A554C882D3AQ35459617-82774222-F71A-49E1-B700-B929796BDA7BQ35579350-2415B267-6897-4148-989A-EFBD0208191BQ35849373-28A75C9E-869D-4117-8295-BFCADA37BF13Q35860227-EDE03B58-6503-484B-B81F-67E24BD6D2FDQ35871872-EC518B3E-7B33-48F5-AF0A-E57F303A6088Q35935129-5ED728C1-ABBD-4AFE-9D0F-1143E735BBCAQ36025421-9996A2A6-D7E9-48BF-B936-21F0CEC3992BQ36147328-23286E82-FC1D-4ED4-9862-750A0BCB30A3Q36175367-4AB6CFE6-C71E-4E12-9B87-6EFFCE64EEB2Q36259344-F9B5D195-6974-4AA0-A3A2-545A441DF65BQ36339330-D925F4FC-1F64-45A6-BC4D-4290D8947BFBQ36473356-42492928-F693-4D8E-A841-5006858CEE13Q36479414-535BB0DE-FF02-4BA8-9D00-C8F65A745512Q36575297-D8A96963-E0DD-4A6A-9C7B-6BB3922FFC2DQ36578199-08640735-02A7-470E-B9A1-393AC01132D2Q36721060-A382E325-08CE-4D1F-80DD-31C2578D2BC2Q36776775-F62683BA-A7AF-494C-9662-82B95154031AQ36860344-A6CFB4CE-328C-433F-9D22-4618299C11C4Q36916109-25F4F38C-6183-4CB0-95A3-57A6DA95B3DFQ37000604-742C8746-3BD3-40C6-AC4E-6805241124DAQ37083154-15FEDDC4-F9AA-4EC5-BFC6-B47EC01EAD90
P2860
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peripheral endocannabinoid dys ...... od deprivation and re-feeding.
@en
Peripheral endocannabinoid dys ...... od deprivation and re-feeding.
@nl
type
label
Peripheral endocannabinoid dys ...... od deprivation and re-feeding.
@en
Peripheral endocannabinoid dys ...... od deprivation and re-feeding.
@nl
prefLabel
Peripheral endocannabinoid dys ...... od deprivation and re-feeding.
@en
Peripheral endocannabinoid dys ...... od deprivation and re-feeding.
@nl
P2093
P2860
P50
P1476
Peripheral endocannabinoid dys ...... od deprivation and re-feeding.
@en
P2093
Francesca Borrelli
Gabriella Aviello
Stefania Petrosino
P2860
P304
P356
10.1111/J.1476-5381.2009.00183.X
P407
P577
2009-04-03T00:00:00Z